Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (2707)

SortShow
Name Institution Why
George Daniel Demetri, M.D.Dana-Farber Cancer Institute Why?
Ronald Geoffrey Marcus, M.B.,B.Ch.Beth Israel Deaconess Medical Center Why?
Stephen Daniel Wiviott, M.D.Brigham and Women's Hospital Why?
Eugene Braunwald, M.D.Brigham and Women's Hospital Why?
Maurizio Fava, M.D.Massachusetts General Hospital Why?
Ursula Anne Matulonis, M.D.Dana-Farber Cancer Institute Why?
David Andrew Morrow, M.D.Brigham and Women's Hospital Why?
Jonathan A. Fletcher, M.D.Brigham and Women's Hospital Why?
George I Papakostas, M.D.Massachusetts General Hospital Why?
James Douglas Griffin, M.D.Dana-Farber Cancer Institute Why?
Benjamin Morgan Scirica, M.D.Brigham and Women's Hospital Why?
Richard Leonard Verrier, Ph.D.Beth Israel Deaconess Medical Center Why?
Elliott Marshall Antman, M.D.Brigham and Women's Hospital Why?
Ellen L. Weisberg, Ph.D.Dana-Farber Cancer Institute Why?
Gary Steven Sachs, M.D.Massachusetts General Hospital Why?
Per Page    Page  of 181last Nextnext
Prev
Search Criteria
  • Piperazines
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.